Journal Article

Phase I antibody risks, trial safety examined.

Journal of the National Cancer Institute (2006) 98(14) 956-958
DOI: 10.1093/jnci/djj315
1Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Tuma, R. S. (2006). Phase I antibody risks, trial safety examined. Journal of the National Cancer Institute, 98(14), 956–958. https://doi.org/10.1093/jnci/djj315

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free